Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,206,033 papers from all fields of science
Search
Sign In
Create Free Account
Rebastinib Tosylate
The tosylate salt of rebastinib, an orally bioavailable small-molecule inhibitor of multiple tyrosine kinases with potential antineoplastic activity…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Narrower (1)
DCC-2036
Receptor Tyrosine Kinase Inhibition
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract CT021: Phase Ib study of rebastinib plus antitubulin therapy with paclitaxel (P) or eribulin (E) in patients with HER2 negative metastatic breast cancer (MBC)
Jesus Anampa
,
X. Xue
,
+5 authors
J. Sparano
Clinical Trials
2018
Corpus ID: 80895879
BACKGROUND: Metastasis is the primary cause of death in breast cancer, yet no current therapies specifically inhibit metastasis…
Expand
2018
2018
Abstract 67: Chemotherapy induced pro-metastatic changes in the primary breast tumors of racially diverse patients
G. Karagiannis
,
J. Pastoriza
,
+10 authors
M. Oktay
Tumor Biology
2018
Corpus ID: 81419311
Neoadjuvant chemotherapy (NAC) induces influx of bone marrow-derived proangiogenic Tie2hi monocytes into the primary tumor…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE